April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
Posters
High Quality Whole Transcriptome RNA-Sequencing from Challenging Clinical Samples
June 23, 2025
More infoPosters
Performance Evaluation of an Ultra-Sensitive Assay for NSCLC Biomarker Testing
June 23, 2025
More infoCellTalk Blog
CROs vs. CMOs vs. CDMOs: Understanding the Differences in Outsourcing Partners
June 10, 2025
More info